Shota Fujimoto

MRP3 as a novel resistance factor for sorafenib in hepatocellular carcinoma

Tetsu Tomonari, Shunsaku Takeishi, Tatsuya Taniguchi et al. · Oncotarget · 2016 · 66 citations · Full text

Medicine, Oncology, Pharmacology +15

EGFR Downregulation after Anti-EGFR Therapy Predicts the Antitumor Effect in Colorectal Cancer

Yasuyuki Okada, Tetsuo Kimura, Tadahiko Nakagawa et al. · Molecular Cancer Research · 2017 · 62 citations · Full text

Medicine, Oncology, Pharmacology +17

<scp>TIMP1</scp> promotes cell proliferation and invasion capability of right‐sided colon cancers via the <scp>FAK</scp>/Akt signaling pathway

Beibei Ma, Hiroyuki Ueda, Koichi Okamoto et al. · Cancer Science · 2022 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +17

First report of an Asian family with gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) revealed with the germline mutation of the APC exon 1B promoter region

Yasuhiro Mitsui, Reiko Yokoyama, Shota Fujimoto et al. · Gastric Cancer · 2018 · 39 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Utility of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune Inflammation Index as Prognostic, Predictive Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab and Ipilimumab

Koji Iinuma, Torai Enomoto, Kei Kawada et al. · Journal of Clinical Medicine · 2021 · 37 citations · Full text

Medicine, Immunology, Oncology +17